AbCellera Announces Expanded Research Collaboration with Teva
June 13, 2017 09:00 ET
|
AbCellera
VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Teva Pharmaceutical Industries, Ltd....
AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research
June 06, 2017 09:00 ET
|
AbCellera
VANCOUVER, British Columbia, June 06, 2017 (GLOBE NEWSWIRE) -- AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines...
AbCellera Receives Grant to Help Fight Tuberculosis
January 19, 2017 09:00 ET
|
AbCellera
AbCellera received a grant from the Bill & Melinda Gates Foundation to discover antibodies against Mycobacterium tuberculosis.VANCOUVER, British Columbia, Jan. 19, 2017 (GLOBE NEWSWIRE) --...
AbCellera Announces Multi-Target Research Collaboration with Pfizer
January 05, 2017 09:00 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 05, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Pfizer Inc. (NYSE:PFE). AbCellera...
AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates
August 24, 2016 09:00 ET
|
AbCellera
VANCOUVER, British Columbia, Aug. 24, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...
AbCellera and MassBiologics Partner to Discover Fully Human Antibodies Against Drug-Resistant Bacteria
July 20, 2016 09:00 ET
|
AbCellera
VANCOUVER, British Columbia, July 20, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...
Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies
February 02, 2016 08:00 ET
|
AbCellera
JERUSALEM and VANCOUVER, British Columbia, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and AbCellera have entered into a collaborative research...
AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration
January 27, 2016 16:08 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 27, 2016 (GLOBE NEWSWIRE) -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today...
AbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola Virus
January 20, 2016 19:13 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 20, 2016 (GLOBE NEWSWIRE) -- AbCellera announced today successful completion of its first antibody discovery partnership with MassBiologics of the University...